MedTrace Logo

Fecal Microbiota Transplantation (FMT) in Clostridium Difficile Infection (CDI) Not Responding to Antibiotics

NCT03117582 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 34

Last updated 2022-03-28

No results posted yet for this study

Summary

Purpose: To study the changes in the microbiome and stool composition in patients with Clostridium Difficile Infection (CDI) who undergo Fecal Microbiota Transplantation (FMT), along with changes in their clinical characteristics.

Conditions

  • Clostridium Difficile

Interventions

OTHER

Stool specimen

The following stool specimen will be collected for this study: 1. 4, 3mL stool specimen from patient 2. 1, 25mL stool aliquot from donor

Sponsors & Collaborators

  • North Carolina Translational and Clinical Sciences Institute

    collaborator OTHER

  • North Carolina State University

    collaborator OTHER

  • University of North Carolina, Chapel Hill

    lead OTHER

Principal Investigators

  • Ajay S Gulati, MD · UNC Chapel Hill

Eligibility

Min Age
1 Year
Max Age
99 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2016-12-31
Primary Completion
2020-05-02
Completion
2020-12-11

Countries

  • United States

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT03117582 on ClinicalTrials.gov